ADVERTISEMENT
Search
Login JOIN / RENEW

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

Daily statin reduces heart disease risk among adults living with HIV Daily statin reduces heart disease risk among adults living with HIV

Daily statin reduces heart disease risk among adults living with HIV

0 6979
A new study published in NEJM found that cholesterol-lowering statin drugs helped curb the risk of significant CVD in people living with HIV by more than one-third, potentially preventing one in five major CV events or premature deaths in this population.
AHA: Vaping harms heart and lungs AHA: Vaping harms heart and lungs

AHA: Vaping harms heart and lungs

In a new scientific statement, the American Heart Association (AHA) is urging more research about the detrimental effects of vaping on the heart...
0 7122
Is cytisinicline effective for smoking cessation? Is cytisinicline effective for smoking cessation?

Is cytisinicline effective for smoking cessation?

Researchers have found that cytisinicline effectively and safely assisted people with smoking cessation when used at a higher concentration than...
0 4634
State of hepatitis C being cured is dismal for patients State of hepatitis C being cured is dismal for patients

State of hepatitis C being cured is dismal for patients

According to a new CDC report, only one-third of individuals with documented hepatitis C diagnosis were cured over the past decade. Based on data...
0 4005
Weekly insulin found safe, effective for T2D Weekly insulin found safe, effective for T2D

Weekly insulin found safe, effective for T2D

New research published in JAMA shows that once-weekly insulin icodec is safe for people with T2D. It also showed that individuals with T2D who...
0 3845

Almost one-half of Americans would spend $100 a month for weight loss drugs

Nearly one-half of Americans said they would be willing to spend up to $100 a month for new weight loss medicines such as semaglutide (Wegovy—Novo Nordisk), and one-third said they would indefinitely pay whatever they can afford to get the drugs, according to a new survey by STAT and Harris Poll.

First45679111213Last
ADVERTISEMENT